Two studies in Nature show the power of RNA sequencing in exploring the genetic mechanisms that underpin gene expression.

Metastatic bowel cancer treatment, Erbitux, is one of the new generation of highly effective personalised medicine therapies.

New research shows the microRNA, miR-9, plays a significant role in metastasis and blood vessel growth in breast cancer and could provide a target for future therapies.

Garvan researchers find gene silencing in prostate cancer is more substantial than expected and could provide key to battling cancer.

Patent infringement suit brought against nine U.S. biotechnology companies for use of non-coding DNA technology.

A new test aims to reveal the influence of natural selection on the human genome, possibly revealing mutations that lend resistance to disease.

Tom Gonda’s research team at the Diamantina Institute in Brisbane is using new technology to unmask the proto-oncogenes that can cause cancer in mutant form.

Just when things seemed to be going around in circles, some quite unexpected data from WEHI has opened up an exciting new avenue in breast cancer research.

Greg Goodall’s Adelaide research group has explored found tantalising links between the miR-200 gene family and metastasis in a wide range of cancers.

The cotton bollworm, the world's most economically destructive insect pest, is having its genome sequenced.

While Friedreich’s ataxia is a rare disorder, tracking down the role of the protein implicated in the disease has opened up new therapeutic potentials.

A pocket of middle Australia on the northern outskirts of Perth is the setting for a proposed biobanking project that even its instigator, Professor Lyle Palmer of the University of Western Australia, calls “ludicrously ambitious”.

Epigenetics is moving from the laboratory to the clinic and the pharmacy, with several histone deacetylase inhibitors on the market and epigenetic screening likely to become as widespread as genetic screening.

A new study has shown that environmental enrichment ameliorates a motor co-ordination deficit in a mouse model of Rett syndrome.

Dee Carter and her group have revitalised taxonomy in Australia as well as our understanding of the evolution of the Plasmodium species with the discovery of a long-lost cousin. And they came across it at the bottom of Sydney Harbour.

Australian and New Zealand researchers are part of an international project of mutual interest (and age-old bad jokes) – the sequencing of the sheep genome. The difference for the International Sheep Genomics Consortium is the availability of short-read sequencing technology.

Genome-wide association studies show the way forward for global genomic research.